John Nicholson
2014
In 2014, John Nicholson earned a total compensation of $3.3M as Senior Vice President and Chief Financial Officer at Nektar Therapeutics, a 99% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $408,000 |
|---|---|
| Option Awards | $2,342,183 |
| Salary | $542,458 |
| Other | $12,854 |
| Total | $3,305,495 |
Nicholson received $2.3M in option awards, accounting for 71% of the total pay in 2014.
Nicholson also received $408K in non-equity incentive plan, $542.5K in salary and $12.9K in other compensation.
Rankings
In 2014, John Nicholson's compensation ranked 2,695th out of 13,032 executives tracked by ExecPay. In other words, Nicholson earned more than 79.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,695 out of 13,032 | 79th |
Division Manufacturing | 959 out of 4,966 | 81st |
Major group Chemicals And Allied Products | 301 out of 1,686 | 82nd |
Industry group Drugs | 233 out of 1,365 | 83rd |
Industry Pharmaceutical Preparations | 191 out of 1,043 | 82nd |
Source: SEC filing on April 29, 2016.
Nicholson's colleagues
We found four more compensation records of executives who worked with John Nicholson at Nektar Therapeutics in 2014.